AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019
-
Published:2019
Issue:4
Volume:14
Page:247-255
-
ISSN:1661-3791
-
Container-title:Breast Care
-
language:en
-
Short-container-title:Breast Care
Author:
Thill Marc, Jackisch Christian, Janni Wolfgang, Müller Volkmar, Albert Ute-Susann, Bauerfeind Ingo, Blohmer Jens, Budach Wilfried, Dall Peter, Diel Ingo, Fasching Peter A., Fehm Tanja, Friedrich Michael, Gerber Bernd, Hanf Volker, Harbeck Nadia, Huober Jens, Kolberg-Liedtke Cornelia, Kreipe Hans-Heinrich, Krug David, Kühn Thorsten, Kümmel Sherko, Loibl Sibylle, Lüftner Diana, Lux Michael Patrick, Maass Nicolai, Möbus Volker, Müller-Schimpfle Markus, Mundhenke Christoph, Nitz Ulrike, Rhiem Kerstin, Rody Achim, Schmidt Marcus, Schneeweiss Andreas, Schütz Florian, Sinn Hans-Peter, Solbach Christine, Solomayer Erich-Franz, Stickeler Elmar, Thomssen Christoph, Untch Michael, Wenz Frederik, Witzel IsabellORCID, Wöckel Achim, Ditsch Nina
Abstract
Every year the Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO), a group of gynecological oncologists specialized in breast cancer and interdisciplinary members specialized in pathology, radiologic diagnostics, medical oncology, and radiation oncology, prepares and updates evidence-based recommendations for the diagnosis and treatment of patients with early and metastatic breast cancer. Every update is performed according to a documented rule-fixed algorithm, by thoroughly reviewing and scoring the recent publications for their scientific validity and clinical relevance. This current publication presents the 2019 update on the recommendations for metastatic breast cancer.
Reference66 articles.
1. Clark EM, Durup D. Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks? Ther Adv Musculoskelet Dis. 2015 Feb;7(1):11–6. 2. Van Poznak C, Somerfield MR, Barlow WE, Biermann JS, Bosserman LD, Clemons MJ, et al. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. J Clin Oncol. 2017 Dec;35(35):3978–86. 3. Chi MS, Yang KL, Chang YC, Ko HL, Lin YH, Huang SC, et al. Comparing the effectiveness of combined external beam radiation and hyperthermia versus external beam radiation alone in treating patients with painful bony metastases: a phase 3 prospective, randomized, controlled trial. Int J Radiat Oncol Biol Phys. 2018 Jan;100(1):78–87. 4. Gnant M, Pfeiler G, Steger GG, Egle D, Greil R, Fitzal F, et al.; Austrian Breast and Colorectal Cancer Study Group. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019 Mar;20(3):339–51. 5. Coleman RE, Finkelstein D, Barrios CH, Martin M, Iwata H, Glaspy JA, et al. Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study. J Clin Oncol. 2018 May;36(15 suppl):501–501.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|